On June 24, 2020, John Elias, a long-time prosecutor in the U.S. Department of Justice’s (DOJ’s) Antitrust Division, testified before the House Judiciary Committee that, at the direction of Attorney General William P. Barr, the DOJ investigated ten mergers in the cannabis industry despite the lack of any competitive issue and over the objections of the Antitrust Division’s career staff. The reason, Elias says, was that Mr. Barr does not like the product. According to Elias,
For its part, the DOJ has strongly disputed Elias’s account. Spokeswoman Brianna Herlihy said the Department “strongly disagrees with (his) claim that the Antitrust Division acted inappropriately in any investigation.” The Antitrust Division contended that the cannabis industry presented “unique challenges” because the Division “lacked experience with the cannabis industry, that industry was rapidly expanding and consolidating, many cannabis companies are unsophisticated,” and it had only limited ability to collect information “because cannabis is illegal under federal law.” The two whistleblower complaints were reviewed by the DOJ’s Office of Professional Responsibility (OPR), and the night before Elias’s testimony, OPR issued a memo absolving the Antitrust Division of any wrongdoing.
After the House Judiciary Committee hearing, Senator Amy Klobuchar, Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and other Senate democrats  called for an immediate hearing on political interference in antitrust enforcement decisions at the DOJ. According to the letter, “Mr. Elias’s testimony before the House Judiciary Committee [wa]s damning. It eviscerate[d] the notion that investigations and enforcement decisions at today’s Antitrust Division are based on impartial assessments of law and fact.” The Senators have requested testimony from Elias and Antitrust Division head Makan Delrahim. Attorney General William P. Barr has agreed to appear before the House Judiciary Committee on July 28, 2020.
The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.
Cannabis Alert | 12.23.20
Cannabis Alert | 11.20.20